Data / Form D filings / Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc.: Form D filings
Cadrenal Therapeutics, Inc., a biotechnology company in Ponte Vedra, FL, filed 7 Form D notices with the SEC between 2022 and 2026. The latest, on July 15, 2026, reports $8.8 million sold of a $8.8 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 822 A1A NORTH, SUITE 306, Ponte Vedra, FL, 32082
- Phone
- (904) 300-0701
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1937993
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | New notice | $8,843,849 | $8,843,849 | 1 | Jun 30, 2026 | sec.gov | |
| Apr 6, 2026 | New notice | $7,923,235 | $7,923,235 | 1 | Apr 1, 2026 | sec.gov | |
| Dec 31, 2025 | New notice | $4,396,329 | $4,396,329 | 4 | Dec 16, 2025 | sec.gov | |
| Nov 14, 2024 | New notice | $9,428,594 | $9,428,594 | 5 | Nov 1, 2024 | sec.gov | |
| Jul 18, 2023 | New notice | $7,500,001 | $7,500,001 | 1 | Jul 14, 2023 | sec.gov | |
| Dec 8, 2022 | New notice | $1,000,000 | $250,000 | $750,000 | 2 | Nov 30, 2022 | sec.gov |
| Jul 25, 2022 | New notice | $2,000,000 | $150,000 | $1,850,000 | 2 | Jul 12, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Quang X. Pham | Executive Officer, Director | Chairman of the Board and Chief Executive Officer |
| John P. Sharp | Executive Officer | Interim Chief Financial Officer |
| James J. Ferguson | Executive Officer | Chief Medical Officer |
| Jeffrey S. Cole | Executive Officer | Chief Operating Officer |
| Lee Golden | Director | |
| John R. Murphy | Director | |
| Glynn Wilson | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jul 13, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cadrenal Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.